{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:21:14Z","timestamp":1794590474309,"version":"4.9.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12898-3","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T04:35:46Z","timestamp":1771389346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Early procalcitonin kinetics as an independent predictor of mortality in multi-drug resistant Klebsiella spp. bloodstream infections: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Nesibe","family":"Korkmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6n\u00fcl \u00c7i\u00e7ek","family":"\u015eent\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feray Aycan","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclnur","family":"Kul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bedirhan","family":"G\u00fcldo\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice Merve","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Zehra","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hicret","family":"Ertekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asl\u0131 Hayk\u0131r","family":"Solay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semanur","family":"Kuzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Bulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emin Ediz","family":"T\u00fct\u00fcnc\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"12898_CR1","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1517\/14656566.2014.914172","volume":"1510","author":"I Karaiskos","year":"2014","unstructured":"Karaiskos I, Helen G. Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches. Expert Opin Pharmacother. 2014;1510:1351\u201370.","journal-title":"Expert Opin Pharmacother"},{"key":"12898_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jiph.2018.08.002","volume":"121","author":"C Li","year":"2019","unstructured":"Li C, Li Y, Zhao Z, Liu Q, Li B. Treatment options and clinical outcomes for carbapenem-resistant Enterobacteriaceae bloodstream infection in a Chinese university hospital. J Infect Public Health. 2019;121:26\u201331.","journal-title":"J Infect Public Health"},{"key":"12898_CR3","doi-asserted-by":"publisher","first-page":"579462","DOI":"10.3389\/fcimb.2020.579462","volume":"10","author":"FK Lim","year":"2020","unstructured":"Lim FK, Liew YX, Cai Y, Lee W, Teo JQ, Lay WQ, et al. Treatment and outcomes of infections caused by diverse carbapenemase-producing carbapenem-resistant enterobacterales. Front Cell Infect Microbiol. 2020;10:579462.","journal-title":"Front Cell Infect Microbiol"},{"key":"12898_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.33393\/dti.2023.2622","volume":"17","author":"A So-Ngern","year":"2023","unstructured":"So-Ngern A, Osaithai N, Meesing A, Chumpangern W. Mortality rate and factors associated with mortality of carbapenem-resistant Enterobacteriaceae infection. Drug Target Insights. 2023;17:120.","journal-title":"Drug Target Insights"},{"key":"12898_CR5","doi-asserted-by":"crossref","unstructured":"Balkhair A, Al Saadi K, Al Adawi B. Epidemiology and mortality outcome of carbapenem-and colistin-resistant Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, and Pseudomonas aeruginosa bloodstream infections. IJID regions. 2023;7:1\u20135.","DOI":"10.1016\/j.ijregi.2023.01.002"},{"issue":"2","key":"12898_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1089\/mdr.2017.0061","volume":"24","author":"P Liu","year":"2018","unstructured":"Liu P, Li X, Luo M, Xu X, Su K, Chen S, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection: a meta-analysis. Microb Drug Resist. 2018;24(2):190\u20138.","journal-title":"Microb Drug Resist"},{"key":"12898_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.02349-16","volume":"61","author":"MJ Satlin","year":"2017","unstructured":"Satlin MJ, Chen L, Patel G, Gomez Simmonds A, Weston G, Kim AC, et al. Multicenter clinical and molecular epidemiological analysis of bacteremia due to carbapenem-resistant Enterobacteriaceae (CRE) in the CRE epicenter of the united States. Antimicrob Agents Chemother. 2017;61:4:10\u20131128.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"12898_CR8","doi-asserted-by":"publisher","first-page":"e02603","DOI":"10.1128\/spectrum.02603-21","volume":"10","author":"Y Chen","year":"2022","unstructured":"Chen Y, Huang HB, Peng JM, Weng L, Du B. Efficacy and safety of ceftazidime-avibactam for the treatment of carbapenem-resistant enterobacterales bloodstream infection: a systematic review and meta-analysis. Microbiol Spectr. 2022;10(2):e02603\u201321.","journal-title":"Microbiol Spectr"},{"key":"12898_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/cid\/cix783","volume":"662","author":"D Van Duin","year":"2018","unstructured":"Van Duin D, Lok JJ, Earley M, Cober E, Richter SS, Perez F, et al. Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae. Clin Infect Dis. 2018;662:163\u201371.","journal-title":"Clin Infect Dis"},{"key":"12898_CR10","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/cid\/ciy492","volume":"683","author":"M Tumbarello","year":"2019","unstructured":"Tumbarello M, Trecarichi EM, Corona A, De Rosa FG, Bassetti M, Mussini C, et al. Efficacy of ceftazidime-avibactam salvage therapy in patients with infections caused by Klebsiella pneumoniae carbapenemase\u2013producing K. pneumoniae. Clin Infect Dis. 2019;683:355\u201364.","journal-title":"Clin Infect Dis"},{"key":"12898_CR11","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/jac\/dkaa503","volume":"763","author":"I Karaiskos","year":"2021","unstructured":"Karaiskos I, Daikos GL, Gkoufa A, Adamis G, Stefos A, Symbardi S, et al. Ceftazidime\/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a National registry study. J Antimicrob Chemother. 2021;763:775\u201383.","journal-title":"J Antimicrob Chemother"},{"key":"12898_CR12","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1186\/cc12787","volume":"173","author":"P Schuetz","year":"2013","unstructured":"Schuetz P, Maurer P, Punjabi V, Desai A, Amin DN, Gluck E. Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients. Crit Care. 2013;173:R115.","journal-title":"Crit Care"},{"key":"12898_CR13","doi-asserted-by":"publisher","first-page":"706","DOI":"10.14740\/jocmr2251w","volume":"7","author":"F Pieralli","year":"2015","unstructured":"Pieralli F, Vannucchi V, Mancini A, Antonielli E, Luise F, Sammicheli L, et al. Procalcitonin kinetics in the first 72 hours predicts 30-day mortality in severely ill septic patients admitted to an intermediate care unit. J Clin Med Res. 2015;7:9:706.","journal-title":"J Clin Med Res"},{"key":"12898_CR14","first-page":"357","volume":"415","author":"AF Kurt","year":"2024","unstructured":"Kurt AF, Tanr\u0131verdi ES, Yal\u00e7\u0131n M, Bayramlar OF, Kaya SY, Karaali R, et al. Resistance genes and mortality in carbapenem-resistant Klebsiella pneumoniae bacteremias: effects of the COVID-19 pandemic. Balkan Med J. 2024;415:357.","journal-title":"Balkan Med J"},{"issue":"1","key":"12898_CR15","doi-asserted-by":"publisher","first-page":"25805","DOI":"10.1038\/s41598-024-73786-x","volume":"14","author":"C Semet","year":"2024","unstructured":"Semet C, Efe K, Akal\u0131n H, \u0130\u015f\u00e7imen R, Girgin NK, \u00d6zak\u0131n C, et al. Outcome of carbapenem or colistin-resistant Klebsiella pneumoniae bacteremia in the intensive care unit. Sci Rep. 2024;14(1):25805.","journal-title":"Sci Rep"},{"key":"12898_CR16","doi-asserted-by":"publisher","first-page":"6780766","DOI":"10.1155\/cjid\/6780766","volume":"2025","author":"JM Chang","year":"2025","unstructured":"Chang JM, Lin KH, Lai CH, Tsai IT, Hsu YC. The prognostic role of Pitt bacteremia score in patients with nonbacteremic Klebsiella pneumoniae infections. Can J Infect Dis Med Microbiol. 2025;2025:1: 6780766.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"9","key":"12898_CR17","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/cid\/ciz528","volume":"70","author":"H Henderson","year":"2020","unstructured":"Henderson H, Luterbach CL, Cober E, Richter SS, Salata RA, Kalayjian RC, et al. The Pitt bacteremia score predicts mortality in nonbacteremic infections. Clin Infect Dis. 2020;70(9):1826\u201333.","journal-title":"Clin Infect Dis"},{"key":"12898_CR18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/SHK.0b013e318182f98f","volume":"312","author":"JY Rhee","year":"2009","unstructured":"Rhee JY, Kwon KT, Ki HK, Shin SY, Jung DS, Chung DR, et al. Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the acute physiology and chronic health evaluation II scoring systems. Shock. 2009;312:146\u201350.","journal-title":"Shock"},{"issue":"1","key":"12898_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13756-022-01204-w","volume":"11","author":"J Chen","year":"2022","unstructured":"Chen J, Ma H, Huang X, Cui Y, Peng W, Zhu F, et al. Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in china: an eight-year retrospective study. Antimicrob Resist Infect Control. 2022;11(1):161.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"12898_CR20","doi-asserted-by":"publisher","first-page":"13041","DOI":"10.1038\/s41598-024-63864-5","volume":"14","author":"Z Ma","year":"2024","unstructured":"Ma Z, Lai C, Zhang J, Han Y, Xin M, Wang J, et al. High mortality associated with inappropriate initial antibiotic therapy in hematological malignancies with Klebsiella pneumoniae bloodstream infections. Sci Rep. 2024;14(1):13041.","journal-title":"Sci Rep"},{"issue":"1","key":"12898_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s41182-025-00811-8","volume":"53","author":"B Kayaaslan","year":"2025","unstructured":"Kayaaslan B, Kaya Kalem A, Bolat F, C\u0131nar T, D\u00f6nertas Turan G, Pepeler S, et al. Gram-negative bacterial bloodstream infections in cancer patients: a study of epidemiological trends and antibiotic susceptibility. Trop Med Health. 2025;53(1):131.","journal-title":"Trop Med Health"},{"key":"12898_CR22","first-page":"16","volume":"211","author":"M Selvan","year":"2019","unstructured":"Selvan M, Deepashree R, Bhat P, Akshatha R, Jayakar S, Sastry AS. Appropriateness of antimicrobial therapy for culture-proven blood stream infections. J Acad Clin Microbiologists. 2019;211:16\u201323.","journal-title":"J Acad Clin Microbiologists"},{"key":"12898_CR23","doi-asserted-by":"crossref","unstructured":"Lin YT, Lin SN, Chuang C, Liu SY, Ho YC, Juan CH et al. Risk factors for mortality in patients treated with ceftazidime-avibactam for ceftazidime-avibactam susceptible carbapenem-resistant Klebsiella pneumoniae bacteremia. J Infect Public Health. 2025;102836.","DOI":"10.1016\/j.jiph.2025.102836"},{"issue":"1","key":"12898_CR24","doi-asserted-by":"publisher","first-page":"26337","DOI":"10.1038\/s41598-024-77259-z","volume":"14","author":"A Mert","year":"2024","unstructured":"Mert A, Derin O, Akal\u0131n H, Dumlu R, G\u00fcnde\u015f S, Zengin R, et al. Multicenter evaluation of ceftazidime-avibactam use in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in OXA-48 endemic regions. Sci Rep. 2024;14(1):26337.","journal-title":"Sci Rep"},{"key":"12898_CR25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3947\/ic.2024.0038","volume":"563","author":"SY Park","year":"2024","unstructured":"Park SY, Baek YJ, Kim JH, Seong H, Kim B, Kim YC, et al. Guidelines for antibacterial treatment of carbapenem-resistant enterobacterales infections. Infect Chemother. 2024;563:308.","journal-title":"Infect Chemother"},{"key":"12898_CR26","doi-asserted-by":"publisher","first-page":"107247","DOI":"10.1016\/j.ijantimicag.2024.107247","volume":"64","author":"A Belati","year":"2024","unstructured":"Belati A, Diella L, Bavaro DF, De Santis L, Cotugno S, De Gennaro N, et al. Intravenous fosfomycin as adjunctive therapy for Gram-Negative bacteria bloodstream infections: A propensity score adjusted retrospective cohort study. Int J Antimicrob Agents. 2024;64:2:107247.","journal-title":"Int J Antimicrob Agents"},{"key":"12898_CR27","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1469-0691.2009.02921.x","volume":"162","author":"A Michalopoulos","year":"2010","unstructured":"Michalopoulos A, Virtzili S, Rafailidis P, Chalevelakis G, Damala M, Falagas ME. Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation. Clin Microbiol Infect. 2010;162:184\u20136.","journal-title":"Clin Microbiol Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12898-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12898-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12898-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T09:49:16Z","timestamp":1774518556000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12898-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12898"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12898-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Ankara Etlik City Hospital, Scientific Research Evaluation and Ethics Board (Approval number: AE\u015eH-BADEK2-2025-072, date: 13\/05\/2025). The Ethics Committee of Ankara Etlik City Hospital, Scientific Research Evaluation and Ethics Board waived the requirement for informed consent due to the retrospective design of the study and the use of anonymized patient data. This study was performed in accordance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"632"}}